Elevation Oncology, Inc.

ELEV · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$49,464$49,255$45,917$146,284
Short-Term Investments$43,720$33,852$44,363$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,542$4,857$2,697$3,140
Total Curr. Assets$94,726$87,964$92,977$149,424
Property Plant & Equip (Net)$34$59$98$38
Goodwill$0$0$0$0
Intangibles$0$0$0$38
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$866$1,068$1,086-$6
Total NC Assets$900$1,127$1,184$70
Other Assets$0$0$0$0
Total Assets$95,626$89,091$94,161$149,494
Liabilities
Payables$559$507$6,362$5,648
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,908$3,638$9,330$3,141
Total Curr. Liab.$4,467$4,145$15,692$8,789
LT Debt$31,134$30,137$29,435$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$2$8
Total NC Liab.$31,134$30,137$29,437$8
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$35,601$34,282$45,129$8,797
Equity
Pref Stock$0$0$0$0
Common Stock$6$4$2$2
Retained Earnings-$240,455-$195,970-$150,266-$55,186
AOCI$61$9-$161-$0
Other Equity$300,413$250,766$199,457$195,881
Total Equity$60,025$54,809$49,032$140,697
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$95,626$89,091$94,161$149,494
Net Debt-$18,330-$19,118-$16,482-$146,284